Understanding Circadian Responses to Light in Persons With Mild Cognitive Impairment and Alzheimer's Disease
The study conducted by the Icahn School of Medicine at Mount Sinai aims to explore the effects of different light conditions on melatonin levels and memory in individuals with mild cognitive impairment and healthy controls. Given the increasing prevalence of Alzheimer's disease and related cognitive disorders, this research could lead to novel therapeutic strategies that leverage light exposure to improve cognitive function. The findings may have significant implications for the development of light-based interventions or devices targeting circadian rhythms, potentially creating a new market segment within cognitive health and wellness. Competitively, this study positions the sponsor at the forefront of innovative approaches to managing cognitive decline, although further research and validation will be necessary to establish clinical efficacy and market viability.
Indication: Mild Cognitive Impairment
Modality: medical device
Target: Circadian light exposure and melatonin suppression mechanisms in the context of cognitive impairment.
Sponsor: Icahn School of Medicine at Mount Sinai
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 16, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Circadian light exposure and melatonin suppression mechanisms in the context of cognitive impairment.
View original source fields
Condition raw: Mild Cognitive Impairment, Alzheimer Disease
Condition normalized: Mild Cognitive Impairment, Alzheimer Disease
Modality raw: medical device
Modality normalized: medical device
Target raw: Circadian light exposure and melatonin suppression mechanisms in the context of cognitive impairment.
Target normalized: Circadian light exposure and melatonin suppression mechanisms in the context of cognitive impairment.